Obesity & Weight Management

Get the info you need on these new drug indications as part of our September drug news roundup.

New evidence suggests weight-loss drugs could reduce sleep apnea severity, though they may still fall short of CPAP.

A Health Canada safety review assesses the potential risk of weight loss in children under age six who are prescribed off-label central nervous system stimulants for ADHD.

A family physician’s perspective on diagnostic pitfalls and practical considerations.

New collaboration will focus on improving access to evidence-based care and reducing the stigma of obesity as a chronic disease.

Clinical professor says techs are already facilitating medication access—one of the most significant barriers in obesity treatment.

Recent studies have consistently demonstrated improvements in blood glucose levels, HbA1c and weight among patients on a ketogenic diet.

It’s the third generic semaglutide product approved by the department, though the first two were authorized for the treatment of Type 2 diabetes in adults.

The virtual program combines physician-led assessments with ongoing follow-up care and home delivery of medications.